Use of intratympanic steroid as a primary treatment for sudden sensorineural hearing loss.
Dramatic nature of sudden sensorineural hearing loss sets it apart from most of the conditions, which the otologists face in their practice. It has a reported incidence of 5-20/1,00,000 of population with involvement of both sexes in any age group. Exact aetiology of the disease is not known and most of the cases are idiopathic. Treatment policy differs from centre to centre. This prospective study with intratympanic steroid injection as a primary treatment with or without oral corticosteried therapy results 64% success rate with average hearing gain of 25 dB.
Department of ENT, Gauhati Medical College, Guwahati 781032.
Kalpana
K
Sharma
S C
SC
Goswami
D K
DK
Baruah
D000284:Administration, Oral; D000328:Adult; D001301:Audiometry, Pure-Tone; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome; D014432:Tympanic Membrane
D005938:Glucocorticoids; D008775:Methylprednisolone